StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report issued on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of NASDAQ CALA opened at $0.01 on Friday. Calithera Biosciences has a twelve month low of $0.00 and a twelve month high of $0.12. The business has a 50 day simple moving average of $0.01 and a 200-day simple moving average of $0.01.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.